Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $109,495,412    

Indirect Value

   $148,941,386      
Total Shares   53,734,364      
Total Value   $258,436,798      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,651 Rapt Therapeutics, Inc. $23,310,258 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $83,868,504 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,316,651 Rapt Therapeutics, Inc. $23,310,258 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $83,868,504 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-19 4 B $13.99 $87,043 I/I 6,222 15,942,285 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-22 4 B $13.54 $416,337 I/I 30,760 15,973,045 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-23 4 B $13.35 $410,535 I/I 30,760 16,003,805 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-24 4 B $13.51 $392,502 I/I 29,054 16,032,859 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-25 4 B $13.37 $411,294 I/I 30,753 16,063,612 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-26 4 B $13.59 $408,634 I/I 30,059 16,093,671 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-29 4 B $13.58 $260,727 I/I 19,201 16,112,872 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-30 4 B $13.91 $123,195 I/I 8,855 16,121,727 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-01 4 B $13.98 $36,346 I/I 2,600 16,124,327 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-02 4 B $13.97 $24,898 I/I 1,782 16,126,109 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-05 4 B $13.98 $81,400 I/I 5,824 16,131,933 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-06 4 B $13.96 $4,328 I/I 310 16,132,243 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-07 4 B $14.00 $3,143,000 I/I 224,500 16,356,743 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-08 4 B $13.98 $168 I/I 12 16,356,755 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-09 4 B $13.99 $2,126 I/I 152 16,356,907 2.17 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-09 4 B $10.26 $181,848 I/I 17,724 16,374,631 1.5 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-10 4 B $10.50 $186,102 I/I 17,724 16,392,355 1.5 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-11 4 B $10.57 $187,343 I/I 17,724 16,410,079 1.5 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-14 4 B $10.36 $361,564 I/I 34,900 16,444,979 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-15 4 B $10.31 $342,292 I/I 33,200 16,478,179 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-16 4 B $10.26 $358,074 I/I 34,900 16,513,079 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,519,897 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,554,618 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-21 4 B $11.94 $518,196 I/I 43,400 16,598,018 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,600,318 2.25 -
  145  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us